Literature DB >> 17990358

Expression of matrix metalloproteinase-1 and tumor necrosis factor-alpha in ulcerative colitis.

Ying-De Wang1, Jing-Wei Mao.   

Abstract

AIM: To examine the expression of matrix metallo-proteinase-1 (MMP-1) and tumor necrosis factor-alpha (TNF-alpha) in the colon mucosa of patients with ulcerative colitis (UC).
METHODS: Reverse transcription-polymerase chain reaction (RT-PCR) and immunohistochemistry were used to examine the expression of MMP-1 and TNF-alpha at both mRNA and protein levels in the colon mucosa of patients with UC. Correlation between MMP-1 and TNF-alpha and their correlation with the severity of the disease were also analyzed statistically.
RESULTS: The expression of MMP-1 and TNF-alpha in the ulcerated and inflamed colon mucosa of patients with UC was significantly higher than that in the non-inflamed mucosa of normal controls at both mRNA and protein levels. Furthermore, the expression of MMP-1 and TNF-alpha in the ulcerated area was significantly higher than that in the inflamed area of patients with UC (0.9797 +/- 0.1433 vs 0.6746 +/- 0.0373, 0.8669 +/- 0.0746 vs 0.5227 +/- 0.0435, P < 0.05). There was no statistically significant difference in the non-inflamed area of normal controls. There was a significant correlation between MMP-1 and TNF-alpha expression (0.9797 +/- 0.1433 vs 0.8669 +/- 0.0746, P < 0.05), the correlating factor was 0.877. MMP-1 and TNF-alpha showed a significant correlation with the severity of the disease (0.0915 +/- 0.0044 vs 0.0749 +/- 0.0032 , 0.0932 +/- 0.0019 vs 0.0724 +/- 0.0043, P < 0.05), their correlating factors were 0.942 and 0.890, respectively.
CONCLUSION: Excessively expressed MMP-1 directly damages the colon mucosa by degrading extracellular matrix (ECM) in patients with UC. While damaging colon mucosa, excessively expressed TNF-alpha stimulates MMPs secreting cells to produce more MMP-1 and aggravates the mucosa damage. MMP-1 promotes secretion of TNF-alpha in a positive feedback manner to cause further injury in the colon mucosa. MMP-1 and TNF-alpha correlate well with the severity of the disease, and therefore, can be used clinically as biological markers to judge the severity of UC.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17990358      PMCID: PMC4205439          DOI: 10.3748/wjg.v13.i44.5926

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  29 in total

1.  IL-10 secretion and sensitivity in normal human intestine and inflammatory bowel disease.

Authors:  C Gasche; S Bakos; C Dejaco; W Tillinger; S Zakeri; W Reinisch
Journal:  J Clin Immunol       Date:  2000-09       Impact factor: 8.317

2.  Inflammatory bowel disease: definition, epidemiology, etiologic aspects, and immunogenetic studies.

Authors:  Bing Xia; JBA Crusius; SGM Meuwissen; AS Pe?a
Journal:  World J Gastroenterol       Date:  1998-10       Impact factor: 5.742

Review 3.  Role of matrix metalloproteinases in inflammatory bowel disease.

Authors:  Yuji Naito; Toshikazu Yoshikawa
Journal:  Mol Aspects Med       Date:  2005 Aug-Oct

4.  Beneficial effects of Batimastat (BB-94), a matrix metalloproteinase inhibitor, in rat experimental colitis.

Authors:  P Di Sebastiano; F F di Mola; L Artese; C Rossi; G Mascetta; H Pernthaler; P Innocenti
Journal:  Digestion       Date:  2001       Impact factor: 3.216

5.  A major role for matrix metalloproteinases in T cell injury in the gut.

Authors:  S L Pender; S P Tickle; A J Docherty; D Howie; N C Wathen; T T MacDonald
Journal:  J Immunol       Date:  1997-02-15       Impact factor: 5.422

6.  Increased interleukin 12 production in progressive multiple sclerosis: induction by activated CD4+ T cells via CD40 ligand.

Authors:  K E Balashov; D R Smith; S J Khoury; D A Hafler; H L Weiner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 7.  Cytokines in intestinal inflammation: pathophysiological and clinical considerations.

Authors:  R B Sartor
Journal:  Gastroenterology       Date:  1994-02       Impact factor: 22.682

8.  Infliximab efficacy in pediatric ulcerative colitis.

Authors:  Alexandra P Eidelwein; Carmen Cuffari; Vivian Abadom; Maria Oliva-Hemker
Journal:  Inflamm Bowel Dis       Date:  2005-03       Impact factor: 5.325

9.  Altered Th1/Th2 cytokine profiles in the intestinal mucosa of patients with inflammatory bowel disease as assessed by quantitative reversed transcribed polymerase chain reaction (RT-PCR).

Authors:  M Niessner; B A Volk
Journal:  Clin Exp Immunol       Date:  1995-09       Impact factor: 4.330

10.  Expression and regulation of tissue inhibitor of metalloproteinase-1 and matrix metalloproteinases by intestinal myofibroblasts in inflammatory bowel disease.

Authors:  Brian C McKaig; Daniel McWilliams; Sue A Watson; Yashwant R Mahida
Journal:  Am J Pathol       Date:  2003-04       Impact factor: 4.307

View more
  13 in total

1.  Effects of curcumin and Ginkgo biloba on matrix metalloproteinases gene expression and other biomarkers of inflammatory bowel disease.

Authors:  Tarek Kamal Motawi; Sherine Maher Rizk; Ahmed Hassan Shehata
Journal:  J Physiol Biochem       Date:  2012-04-26       Impact factor: 4.158

2.  Plasma TGF-β1, MMP-1 and MMP-3 Levels in Chronic Pancreatitis.

Authors:  K Sri Manjari; Pratibha Nallari; A Vidyasagar; A Jyothy; A Venkateshwari
Journal:  Indian J Clin Biochem       Date:  2011-09-30

Review 3.  Is there new hope for therapeutic matrix metalloproteinase inhibition?

Authors:  Roosmarijn E Vandenbroucke; Claude Libert
Journal:  Nat Rev Drug Discov       Date:  2014-11-07       Impact factor: 84.694

Review 4.  Mucosal biomarkers in inflammatory bowel disease: key pathogenic players or disease predictors?

Authors:  Franco Scaldaferri; Carmen Correale; Antonio Gasbarrini; Silvio Danese
Journal:  World J Gastroenterol       Date:  2010-06-07       Impact factor: 5.742

5.  Protective role of metalloproteinase inhibitor (AE-941) on ulcerative colitis in rats.

Authors:  Jing-Wei Mao; Xiao-Mei He; Hai-Ying Tang; Ying-De Wang
Journal:  World J Gastroenterol       Date:  2012-12-21       Impact factor: 5.742

Review 6.  Digestive Inflammation: Role of Proteolytic Dysregulation.

Authors:  Vincent Mariaule; Aicha Kriaa; Souha Soussou; Soufien Rhimi; Houda Boudaya; Juan Hernandez; Emmanuelle Maguin; Adam Lesner; Moez Rhimi
Journal:  Int J Mol Sci       Date:  2021-03-10       Impact factor: 5.923

7.  Spontaneous and cytokine induced expression and activity of matrix metalloproteinases in human colonic epithelium.

Authors:  G Pedersen; T Saermark; T Kirkegaard; J Brynskov
Journal:  Clin Exp Immunol       Date:  2009-02       Impact factor: 4.330

Review 8.  Matrix metalloproteinases in inflammatory bowel disease: an update.

Authors:  Shane O'Sullivan; John F Gilmer; Carlos Medina
Journal:  Mediators Inflamm       Date:  2015-04-08       Impact factor: 4.711

Review 9.  Matrix Metalloproteinases in Non-Neoplastic Disorders.

Authors:  Akinori Tokito; Michihisa Jougasaki
Journal:  Int J Mol Sci       Date:  2016-07-21       Impact factor: 5.923

10.  Lipid alterations in experimental murine colitis: role of ceramide and imipramine for matrix metalloproteinase-1 expression.

Authors:  Jessica Bauer; Gerhard Liebisch; Claudia Hofmann; Christian Huy; Gerd Schmitz; Florian Obermeier; Jürgen Bock
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.